Mergers & Acquisitions

Bayer enters one of its most consequential weeks in years, with a Supreme Court hearing on glyphosate liability looming just...

The clock is ticking for BayWa. By the end of April, the German agricultural and energy group must book roughly...

The Allianz share price is closing in on levels not seen since the dot-com era, propelled by a powerful analyst...

Investors in BASF are bracing for a pivotal day on April 30, when the German chemical giant will deliver its...

Nvidia is widening its footprint beyond the chip business, striking a nuclear energy partnership while pouring capital into a data...

Bayer shareholders have handed management a powerful financial weapon. At the company’s annual general meeting, they approved a blanket authorization...

The restructuring of Deutz AG has moved from the drawing board to the execution phase, and investors are about to...

The battle for control of Commerzbank is entering its most critical phase, with two pivotal dates in May set to...

A $1.9 billion merger in the uranium royalty space is casting a spotlight on Uranium Energy Corp, whose minority stake...

The streaming giant is juggling a leadership transition, a potential bargain-priced studio acquisition, and an aggressive push into live sports—all...